Newron Pharmaceuticals
NWRN.SW
#8213
Rank
A$0.25 B
Marketcap
$13.27
Share price
2.15%
Change (1 day)
54.51%
Change (1 year)

Earnings for Newron Pharmaceuticals (NWRN.SW)

Earnings in 2023: -A$27.75 Million

According to Newron Pharmaceuticals's latest financial reports the company's current earnings are A$10.01 Million. In 2023 the company made an earning of -A$27.75 Million, an increase over its 2022 earnings that were of -A$29.04 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Newron Pharmaceuticals from 2005 to 2023

Annual earnings

Year Earnings Change
2023-A$27.75 Million-4.45%
2022-A$29.04 Million11.19%
2021-A$26.12 Million-30.14%
2020-A$37.39 Million6.84%
2019-A$34.99 Million31.45%
2018-A$26.62 Million170.13%
2017-A$9.86 Million-60.23%
2016-A$24.78 Million-41.46%
2015-A$42.32 Million109.46%
2014-A$20.21 Million22.43%
2013-A$16.51 Million222.49%
2012-A$5.12 Million-60.49%
2011-A$12.95 Million-71%
2010-A$44.66 Million-17.37%
2009-A$54.05 Million52.58%
2008-A$35.43 Million41.24%
2007-A$25.09 Million-25.19%
2006-A$33.53 Million22.45%
2005-A$27.38 Million